S213: BMS-986158, A POTENT BET INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB OR FEDRATINIB IN INTERMEDIATE- OR HIGH-RISK MYELOFIBROSIS (MF): RESULTS FROM A PHASE 1/2 STUDY

• Rosa Ayala,
• Nieves Lopez,
• Adi Shacham Abulafia,
• Maan Alwan,
• Costas K. Yannakou,
• Indu Raman,
• Vincent Ribrag,
• Chun Yew Fong,
• Yulia Volchek,
• Massimiliano Bonifacio,
• Alessandra Tucci,
• Jean-Jacques Kiladjian,
• Jésus Marïa Hernandez Rivas,
• Blanca Xicoy,
• Haifa Kathrin Al-Ali,
• Jean-Christope Ianotto,
• Si Tuen Lee-Hoeflich,
• Sharmilla Das,
• Bin Wu,
• Palanikumar Ravindran,
• Qian Zhao,
• Guan Wang,
• Oriana Esposito,
• Yu Liu,
• Zariana Nikolova,
• Christopher Tehlirian,
• Shodeinde Coker,
• David Lavie

Affiliations

Rosa Ayala

1 Hematology and Hemotherapy Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, CIBERONC, Madrid, Spain

Nieves Lopez

2 Hematology and Hemotherapy Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, CIBERON, Madrid, Spain

Adi Shacham Abulafia

3 Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel

Maan Alwan

4 Perth Blood Institute, West Perth, Australia

Costas K. Yannakou

5 Epworth HealthCare, Melbourne, Australia

Indu Raman

5 Epworth HealthCare, Melbourne, Australia

Vincent Ribrag

6 Département d’Innovation Thérapeutique et d’Essais Précoces (DITEP), Gustave Roussy Institute, Villejuif, France

Chun Yew Fong

7 Department of Haematology, Austin Health, Heidelberg, Australia

Yulia Volchek

8 Department of Hematology, Assaf Harofeh Medical Center, Zeriffin, Israel

Massimiliano Bonifacio

9 Department of Medicine, Section of Hematology, Verona University and Azienda Ospedaliera Universitaria Integrata, Verona, Italy

Alessandra Tucci

10 Hematology, ASST Spedali Civili di Brescia, Brescia, Italy

Jean-Jacques Kiladjian

11 Centre d’Investigations Cliniques (CIC 1427), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, INSERM, Université Paris Cité, Paris, France

Jésus Marïa Hernandez Rivas

12 Department of Medicine, University of Salamanca, Department of Hematology, Hospital Unicersitario de Salamanca, Salamanca, Spain

Blanca Xicoy

13 Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

Haifa Kathrin Al-Ali

14 Universitätsklinikum Halle, Halle, Germany

Jean-Christope Ianotto

15 Centre Hospitalier Universitaire de Brest, Brest, France

Si Tuen Lee-Hoeflich

16 Bristol Myers Squibb, Cambridge, United States

Sharmilla Das

17 Bristol Myers Squibb, Princeton, United States

Bin Wu

16 Bristol Myers Squibb, Cambridge, United States

Palanikumar Ravindran

18 Bristol Myers Squibb, Lawrenceville, United States

Qian Zhao

18 Bristol Myers Squibb, Lawrenceville, United States

Guan Wang

18 Bristol Myers Squibb, Lawrenceville, United States

Oriana Esposito

19 Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain

Yu Liu

16 Bristol Myers Squibb, Cambridge, United States

Zariana Nikolova

19 Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain

Christopher Tehlirian

16 Bristol Myers Squibb, Cambridge, United States

Shodeinde Coker

18 Bristol Myers Squibb, Lawrenceville, United States

David Lavie

20 Hadassah Medical Center, Jerusalem, Israel